相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。YAP manipulates proliferation via PTEN/AKT/mTOR-mediated autophagy in lung adenocarcinomas
Wei Xu et al.
CANCER CELL INTERNATIONAL (2021)
The Hippo Signaling Pathway in Drug Resistance in Cancer
Renya Zeng et al.
CANCERS (2021)
Recent Therapeutic Approaches to Modulate the Hippo Pathway in Oncology and Regenerative Medicine
Evan R. Barry et al.
CELLS (2021)
Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma
Tracy T. Tang et al.
MOLECULAR CANCER THERAPEUTICS (2021)
mTORC2-mediated direct phosphorylation regulates YAP activity promoting, glioblastoma growth and invasive characteristics
Brent Holmes et al.
NEOPLASIA (2021)
A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1
Catherine J. Libby et al.
CELL ADHESION & MIGRATION (2021)
Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer
Marteinn Thor Snaebjornsson et al.
CELL METABOLISM (2020)
mTOR at the nexus of nutrition, growth, ageing and disease
Grace Y. Liu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis
Xiaobo Wang et al.
CELL METABOLISM (2020)
Integration of Hippo-YAP Signaling with Metabolism
Consuelo Ibar et al.
DEVELOPMENTAL CELL (2020)
LDLreceptor-related proteinLRP6 senses nutrient levels and regulates Hippo signaling
Wonyoung Jeong et al.
EMBO REPORTS (2020)
Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine
Anwesha Dey et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
O-GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity
Eunah Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Twist-mediated PAR1 induction is required for breast cancer progression and metastasis by inhibiting Hippo pathway
Yifan Wang et al.
CELL DEATH & DISEASE (2020)
Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling
Jeffrey K. Holden et al.
CELL REPORTS (2020)
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Patricia Rada et al.
CELL DEATH & DISEASE (2020)
Naturally occurring hotspot cancer mutations in Gα13 promote oncogenic signaling
Marcin Maziarz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Mechanical force regulation of YAP by F-actin and GPCR revealed by super-resolution imaging
Jing Gao et al.
NANOSCALE (2020)
The interaction between ferroptosis and lipid metabolism in cancer
Dingshan Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
A functional interaction between Hippo-YAP signalling and SREBPs mediates hepatic steatosis in diabetic mice
Zhiping Shu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling
Xiao Zheng et al.
MOLECULAR CANCER (2019)
YAP promotes multi-drug resistance and inhibits autophagy-related cell death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway
Yuan Zhou et al.
CANCER CELL INTERNATIONAL (2019)
Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling
Jiao Wu et al.
NATURE (2019)
ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy
Yuan Tian et al.
NATURE COMMUNICATIONS (2019)
Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)
Ping-Chih Hsu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Lysophosphatidic acid-induced YAP/TAZ activation promotes developmental angiogenesis by repressing Notch ligand Dll4
Daisuke Yasuda et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status
Xuefei Feng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study
Alina M. Allen et al.
JOURNAL OF HEPATOLOGY (2019)
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer
Mi Ran Yun et al.
EMBO MOLECULAR MEDICINE (2019)
Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities
Philamer C. Calses et al.
TRENDS IN CANCER (2019)
YAP/TAZ Signaling and Resistance to Cancer Therapy
Chan D. K. Nguyen et al.
TRENDS IN CANCER (2019)
AMOT is required for YAP function in high glucose induced liver malignancy
Ya Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis
Ruochan Chen et al.
HEPATOLOGY (2018)
YAP/TAZ Activation as a Target for Treating Metastatic Cancer
Janine S. A. Warren et al.
CANCERS (2018)
Interplay between YAP/TAZ and Metabolism
Ja Hyun Koo et al.
CELL METABOLISM (2018)
Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway
Zhiqiang Li et al.
CANCER CELL (2018)
Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth
Andrew G. Cox et al.
EMBO JOURNAL (2018)
Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of Yap
Youngmin A. Lee et al.
NATURE COMMUNICATIONS (2018)
Targeting metastasis-initiating cells through the fatty acid receptor CD36
Gloria Pascual et al.
NATURE (2017)
FOXC2 positively regulates YAP signaling and promotes the glycolysis of nasopharyngeal carcinoma
Lijuan Song et al.
EXPERIMENTAL CELL RESEARCH (2017)
Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation
Changmin Peng et al.
MOLECULAR CELL (2017)
SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology
Hitoshi Shimano et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Protein O-GlcNAcylation: emerging mechanisms and functions
Xiaoyong Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis
Xiao Zhang et al.
NATURE COMMUNICATIONS (2017)
JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity
Juan Ye et al.
CANCER RESEARCH (2017)
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma
Erika Cosset et al.
CANCER CELL (2017)
LncRNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism
Xin Zheng et al.
EMBO JOURNAL (2017)
GPCR-Mediated Signaling of Metabolites
Anna Sofie Husted et al.
CELL METABOLISM (2017)
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
Xiaobo Wang et al.
CELL METABOLISM (2016)
The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation
Yael Aylon et al.
GENES & DEVELOPMENT (2016)
Proton-sensing GPCR-YAP Signalling Promotes Cancer-associated Fibroblast Activation of Mesenchymal Stem Cells
Hongyi Zhu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
O-GIcNAcylation in Cancer Biology: Linking Metabolism and Signaling
Christina M. Ferrer et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway
PuiYee Chan et al.
NATURE CHEMICAL BIOLOGY (2016)
Aerobic glycolysis tunes YAP/TAZ transcriptional activity
Elena Enzo et al.
EMBO JOURNAL (2015)
Proton-sensing GPCR-YAP Signalling Promotes Cell Proliferation and Survival
Hongyi Zhu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2015)
Nonalcoholic Fatty Liver Disease A Systematic Review
Mary E. Rinella
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness
Nicholas Artinian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway
Jung-Soo Mo et al.
NATURE CELL BIOLOGY (2015)
AMPK modulates Hippo pathway activity to regulate energy homeostasis
Wenqi Wang et al.
NATURE CELL BIOLOGY (2015)
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
Luping Lin et al.
NATURE GENETICS (2015)
mTORC2 Regulates Cardiac Response to Stress by Inhibiting MST1
Sebastiano Sciarretta et al.
CELL REPORTS (2015)
Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling
J. Luo et al.
ONCOGENE (2014)
Energy Stress Regulates Hippo-YAP Signaling Involving AMPK-Mediated Regulation of Angiomotin-like 1 Protein
Michael DeRan et al.
CELL REPORTS (2014)
Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation
Fa-Xing Yu et al.
GENES & DEVELOPMENT (2013)
Cholesterol masks membrane glycosphingolipid tumor-associated antigens to reduce their immunodetection in human cancer biopsies
Anton Novak et al.
GLYCOBIOLOGY (2013)
Amot130 Adapts Atrophin-1 Interacting Protein 4 to Inhibit Yes-associated Protein Signaling and Cell Growth
Jacob J. Adler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The SLC2 (GLUT) family of membrane transporters
Mike Mueckler et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake
William A. Flavahan et al.
NATURE NEUROSCIENCE (2013)
Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases
Jacob J. Adler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Fa-Xing Yu et al.
CELL (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Identification of Serum-Derived Sphingosine-1-Phosphate as a Small Molecule Regulator of YAP
Eric Miller et al.
CHEMISTRY & BIOLOGY (2012)
Lipids in Liver Disease: Looking Beyond Steatosis
Robert F. Schwabe et al.
GASTROENTEROLOGY (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
Hippo-YAP and mTOR pathways collaborate to regulate organ size
Alfred Csibi et al.
NATURE CELL BIOLOGY (2012)
YAP mediates crosstalk between the Hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29
Karen Tumaneng et al.
NATURE CELL BIOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
Bin Zhao et al.
GENES & DEVELOPMENT (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
CD44 Attenuates Activation of the Hippo Signaling Pathway and Is a Prime Therapeutic Target for Glioblastoma
Yin Xu et al.
CANCER RESEARCH (2010)
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF beta-TRCP
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 Ligase
Chen-Ying Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Large-scale Proteomics Analysis of the Human Kinome
Felix S. Oppermann et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
BrafV600E cooperates with Pten loss to induce metastatic melanoma
David Dankort et al.
NATURE GENETICS (2009)
Liver lipid metabolism
P. Nguyen et al.
JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION (2008)
Non-alcoholic fatty liver disease: The mist gradually clears
Nimantha Mark Wilfred de Alwis et al.
JOURNAL OF HEPATOLOGY (2008)
A lipidomic analysis of nonalcoholic fatty liver disease
Puneet Puri et al.
HEPATOLOGY (2007)
G-protein-coupled receptors and cancer
Robert T. Dorsam et al.
NATURE REVIEWS CANCER (2007)
The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP
JB Huang et al.
CELL (2005)
The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis
KF Harvey et al.
CELL (2003)
分享论文
